Captrust Financial Advisors Bluebird Bio, Inc. Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 237,648 shares of BLUE stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

237,648

Previous 160,355 48.2%

Holding current value

$1.82 Million

Previous $157,000 21.66%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.47 - $1.35 $36,327 - $104,345	77,293 Added 48.2%	237,648 $123,000
Q2 2024 Aug 14, 2024	SELL	$0.85 - $1.26 $133,816 - $198,363	-157,431 Reduced 49.54%	160,355 $157,000
Q1 2024 May 15, 2024	BUY	$0.91 - $1.75 $210,382 - $404,582	231,190 Added 266.98%	317,786 $406,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $26,567 - $97,213	20,127 Added 30.28%	86,596 $119,000
Q3 2023 Nov 14, 2023	BUY	$3.02 - $4.05 $52,834 - $70,854	17,495 Added 35.72%	66,469 $202,000
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $99,605 - $179,576	35,701 Added 268.97%	48,974 $161,000
Q1 2023 May 15, 2023	SELL	$3.14 - $8.22 $9,313 - $24,380	-2,966 Reduced 18.26%	13,273 $42,000
Q4 2022 Feb 15, 2023	BUY	$5.77 - $8.49 $9,001 - $13,244	1,560 Added 10.63%	16,239 $112,000
Q3 2022 Nov 16, 2022	BUY	$3.75 - $7.39 $10,125 - $19,953	2,700 Added 22.54%	14,679 $93,000
Q2 2022 Aug 16, 2022	SELL	$2.94 - $5.23 $1,643 - $2,923	-559 Reduced 4.46%	11,979 $50,000
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $11,233 - $29,256	-2,760 Reduced 18.04%	12,538 $61,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $26,593 - $48,408	-2,968 Reduced 16.25%	15,298 $153,000
Q3 2021 Nov 16, 2021	SELL	$11.24 - $21.0 $62,764 - $117,264	-5,584 Reduced 23.41%	18,266 $349,000
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $68,281 - $83,610	3,785 Added 18.86%	23,850 $763,000
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $124,590 - $254,513	7,510 Added 59.82%	20,065 $605,000
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $60,472 - $83,386	-2,199 Reduced 14.9%	12,555 $543,000
Q3 2020 Nov 17, 2020	BUY	$34.44 - $43.75 $121,779 - $154,700	3,536 Added 31.52%	14,754 $795,000
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $98,635 - $167,192	3,637 Added 47.98%	11,218 $685,000
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $37,670 - $91,440	1,440 Added 23.45%	7,581 $322,000
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $288,381 - $378,715	6,141 New	6,141 $530,000
Q3 2018 Nov 15, 2018	SELL	$88.86 - $117.49 $1,421 - $1,879	-16 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$99.64 - $127.59 $1,594 - $2,041	16 New	16 $3,000

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $591M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Bluebird Bio, Inc. Transaction History